MecRx has secured a $4 million investment from the Medical Research Commercialisation Fund to advance its breakthrough technology for accelerating drug discovery. [ + ]

Researchers have proposed a way to improve the beam quality of laser wakefield accelerators, also known as benchtop accelerators. [ + ]

The Prostate Cancer Foundation of Australia has opened its annual funding round with the aim of supporting groundbreaking prostate cancer research. [ + ]

Two proteins from the tuberculosis bacterium are showing promising results in investigations in mice for a new vaccine. [ + ]

Living Cell Technologies has received approval from the Auckland Hospital Research Review Committee for its Phase IIb clinical trial of NTCELL for Parkinson's disease. [ + ]

Forensic researchers have established science-based standards for identifying human remains based on X-rays of an individual's spine, upper leg or the side of the skull. [ + ]

The Turnbull government has appointed the Expert Working Group that will help set the direction of Australia's research infrastructure and priorities over the coming decade. [ + ]

OneVentures has closed a $19.7 million financing round for Clinical Genomics, an Australian company set to launch its next-generation blood-based diagnostic tool for colorectal cancer. [ + ]

The National Health and Medical Research Council has awarded grants totalling $3.3 million to two trials into the effects of wind farms on human health. [ + ]

The University of Adelaide has led research into the role of specialist bacteria in the formation and movement of platinum and related metals in surface environments. [ + ]

Scientists have created a map for the future of Australian stem cell science, saying the country has the potential to revolutionise medicine and become a world leader in stem cell research. [ + ]

Researchers have developed a 3D-printable material that opens the way to personalised cancer treatment by enabling multiple, simultaneous tests to find the correct therapy to target a particular tumour. [ + ]

Clarity Pharmaceuticals is one of 15 lucky companies that this month received grant funding through Accelerating Commercialisation. [ + ]

Starpharma's Priostar dendrimer technology has been licensed for the development of an enhanced 2,4-D herbicide for the US market. [ + ]

Researchers have discovered how two pathways cooperate to unleash the immune system's assassins, called cytotoxic or 'killer' T cells. [ + ]